About NewLimit

NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.

Position

NewLimit is seeking a highly motivated Scientist/Senior Scientist in Immunology to lead and execute key discovery-to-preclinical research efforts in inflammatory and autoimmune diseases, with a strong emphasis on T cell and regulatory T cell (Treg) biology. This role will design and implement in vitro screening assays to support lead selection and contribute to preclinical efficacy, safety, and mechanism-of-action studies. You will work closely with cross-functional partners to support program advancement toward IND-enabling studies.

What you'll do

In your role as a Scientist, you will:

• Collaborate with Single Cell Technology, Epigenetic Editing, and Predictive Modeling teams